Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-29 Purchase |
2024-09-03 5:38 pm |
Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER |
154,500 | $0.69498 | $107,375 | 843,941 (Direct) |
View |
| 2023-08-10 Purchase |
2023-08-11 4:15 pm |
Quince Therapeutics Inc. | QNCX | Thye Dirk Chief Executive Officer |
88,000 | $1.26 | $110,880 | 448,911 (Direct) |
View |
| 2023-08-08 Purchase |
2023-08-09 6:23 pm |
Quince Therapeutics Inc. | QNCX | Thye Dirk Chief Executive Officer |
80,000 | $1.24 | $99,200 | 360,911 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-28 Option Award |
2025-02-11 5:44 pm |
N/A 2035-01-27 |
Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER |
1,200,000 | $0 | 1,200,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 5:50 pm |
N/A 2034-01-31 |
Quince Therapeutics Inc. | QNCX | Thye Dirk CEO AND CHIEF MEDICAL OFFICER |
1,500,000 | $0 | 1,500,000 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-17 4:48 pm |
N/A N/A |
Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER |
149,999 | $0.94 | 1,255,302 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-17 4:48 pm |
N/A N/A |
Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER |
90,531 | $0.55 | 1,255,302 (Direct) |
View |
| 2024-01-16 Exercise |
2024-01-17 4:48 pm |
N/A 2022-03-27 |
Quince Therapeutics Inc. | QNCX | Thye Dirk CHIEF EXECUTIVE OFFICER |
240,530 | $0 | 1,255,302 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 6:37 pm |
N/A 2033-01-31 |
Quince Therapeutics Inc. | QNCX | Thye Dirk Chief Executive Officer |
600,000 | $0 | 600,000 (Direct) |
View |
| 2022-05-19 Option Award(A) |
2022-05-27 5:35 pm |
N/A N/A |
Cortexyme Inc. | CRTX | Thye Dirk Chief Executive Officer |
216,322 | $0 | 280,911 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-23 8:29 pm |
N/A 2022-03-27 |
Cortexyme Inc. | CRTX | Thye Dirk Chief Executive Officer |
2,250,630 | $0 | 2,250,630 (Direct) |
View |